Liposomal<unk>  is a fixed-dose combination of liposomal bound cytarabine and<unk>  that delivers the two medications in a 5:1 molar ratio. It is used in the treatment of therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).
Daunorubicin/cytarabine
Cladribine
Fludarabine
Clofarabine
Ifosfamide
Cytarabine
Cyclophosphamide
Epirubicin